Table 3 Hazard ratios of baseline characteristics for all-cause mortality among coronary artery bypass surgery patients (univariate analysis)
Variable | Hazard ratio (95% confidence interval) | p Value |
|---|---|---|
Male | 0.63 (0.45–0.87) | 0.005 |
Age (per year) | 1.06 (1.06–1.09) | <0.001 |
Race (Caucasian) | 1.40 (0.78-2.53) | 0.26 |
Body Mass Index (kg/m2) (31+) | ||
18–25 | 1.35 (0.90–2.03) | 0.14 |
26–30 | 1.11 (0.75–1.64) | 0.60 |
Ejection fraction (%) | 1.01 (0.99–1.02) | 0.46 |
Hypertension | 1.31 (0.89–1.93) | 0.17 |
Smoking | 0.89 (0.65–1.23) | 0.48 |
Chronic pulmonary disease | 2.02 (1.37–2.96) | <0.001 |
Prior myocardial infarction | 1.00 (0.73–1.37) | 0.99 |
Prior coronary angioplasty | 1.16 (0.81–1.65) | 0.41 |
Prior coronary artery bypass graft | 0.67 (0.21–2.09) | 0.48 |
Congestive heart failure | 1.64 (1.11–2.43) | 0.01 |
Prior cerebrovascular event | 1.79 (1.22–2.62) | 0.003 |
Family history of coronary artery disease | 0.56 (0.39–0.80) | 0.001 |
Renal Failure on Dialysis | 3.95 (2.19–7.12) | <0.001 |
Diabetes Mellitus | 1.60 (1.17–2.21) | 0.004 |
Peripheral arterial disease | 1.39 (0.91–2.14) | 0.12 |
Pre-Operative CCS | 1.01 (0.87–1.18) | 0.85 |
Pre-Operative NYHA | 0.86 (0.71–1.06) | 0.15 |
Pre-Operative Leukocyte | 1.05 (0.99–1.11) | 0.11 |
Pre-Operative Neutrophils | 1.08 (1.02–1.15) | 0.01 |
Pre-Operative Lymphocytes | 0.69 (0.55–0.88) | 0.003 |
Pre-Operative Monocytes | 1.46 (0.91–2.36) | 0.11 |
Pre-Operative Creatinine | 1.20 (1.09–1.31) | <0.001 |
Pre-Operative Glucose | 1.00 (1.00–1.01) | <0.001 |
Pre-Operative NLR | 1.09 (1.06–1.13) | <0.001 |
Operative and postoperative data | ||
Internal mammary artery used | 0.35 (0.21–0.57) | <0.001 |
Number of conduits used for bypass | 0.96 (0.82–1.13) | 0.64 |
Renal failure on dialysis | 6.80 (3.91–11.80) | <0.001 |
Cardiopulmonary bypass | 1.76 (1.11–2.79) | 0.01 |
New onset atrial fibrillation | 2.03 (1.41–2.91) | <0.001 |
Septicemia | 6.95 (3.54–13.65) | <0.001 |